RecruitingNCT06785597
EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms
Studying Mixed neuroendocrine and non-neuroendocrine neoplasm of pancreas
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Institute of Oncology
- Principal Investigator
- Nicola Fazio, MD, MDEuropean Institute of Oncology
- Enrollment
- 130 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- European Institute of Oncology, Milan, Italy
Collaborators
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06785597 on ClinicalTrials.gov